Table 2 Patients’s status at the end of the study according to ESMO-ESGO-ESTRO modified risk assessment (ESMO 2015)
ESMO 2015 risk group | Status of patients at the end of the study (n = 163) | ||||
|---|---|---|---|---|---|
Alive (no evidence of disease) | Disease progression | Cancer-related death | Non cancer related death | Total | |
1 | 27 (20.8%) | 1 (8.33%) | 0 | 0 | 28 (17.2%) |
2 | 30 (23.1%) | 0 | 0 | 1 (100%) | 31 (19.0%) |
3 | 11 (8.4%) | 0 | 2 (10%) | 0 | 13 (8.0%) |
4 | 57 (43.8%) | 7 (58.33%) | 11 (55%) | 0 | 75 (46.0%) |
5 | 5 (3.9%) | 4 (33.33) | 5 (25%) | 0 | 14 (8.6%) |
6 | 0 | 0 | 2 (10%) | 0 | 2 (1.2%) |
Total | 130 (100%) | 12 (100%) | 20 (100%) | 1 (100%) | 163 (100%) |